同步放化疗前及治疗期间循环肿瘤细胞的变化与局部晚期头颈癌患者生存相关
本研究评估基线及同步放化疗期间循环肿瘤细胞(CTC)在头颈鳞状细胞癌患者中的作用。采用负筛选策略和流式细胞术检测CTC。47例放化疗有效者的CTC计数在2-4周内显著下降(P<0.001),CTC变化与无进展生存(PFS,P=0.01)和总生存(OS,P=0.01)相关,CTC下降状态是多因素分析中PFS(P=0.03)和OS(P=0.05)的独立预后因素。
要点
- 基线CTC与分期显著相关(P=0.001)。
- 47例放化疗有效者CTC计数在2-4周内显著降低(P<0.001)。
- CTC下降状态是PFS(P=0.03)和OS(P=0.05)的独立预后因素。
核心结论
- 在放化疗有效者中,CTC显著减少;第一个月内CTC下降提示更长的PFS和OS,提示CTC动态变化可能比单纯CTC数量更重要。
研究设计与样本
- 研究采用负筛选策略和流式细胞术检测CTC,评估基线及同步放化疗期间CTC在头颈鳞状细胞癌患者中的作用。
主要发现
- 基线CTC与分期显著相关(P=0.001)。
- 47例同步放化疗有效者的CTC计数在2-4周内显著降低(P<0.001)。
- CTC计数变化与无进展生存(PFS,P=0.01)和总生存(OS,P=0.01)相关。
- 多因素分析中,CTC下降状态是PFS(P=0.03)和OS(P=0.05)的独立预后因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the role of baseline circulating tumor cells (CTCs) before and during concurrent chemoradiotherapy and attempted to determine the impacts of CTCs on the outcomes in patients with head and neck squamous cell carcinoma. METHODS: CTCs were detected using a negative selection strategy and flow cytometry protocol. RESULTS: We observed a significant correlation between baseline CTCs and staging (P = 0.001). The CTC counts were significantly reduced within 2-4 weeks in 47 concurrent chemoradiotherapy responders (P < 0.001). Change of CTC counts correlates with progression-free survival (PFS, P = 0.01) and overall survival (OS, P = 0.01). CTC decline status was an independent prognostic factor in PFS (P = 0.03) and OS (P = 0.05) in multivariate analyses. CONCLUSION: In chemoradiotherapy responders, CTCs are significantly reduced. CTC decline within the first month indicates a longer PFS and OS, suggesting that the dynamics of CTCs could be more important than CTC number alone.
引用
- Wang HM, Wu MH, Chang PH, et al. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer. Head Neck. 2019. PMID: 30903634. doi:10.1002/hed.25744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。